WILLIAM ROSS: Open Payments
NPI 1982172029 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 19 payments from 6 companies in 2025. Trend: 2023 $98 · 2024 $128 · 2025 $552
Food & beverage: $409Education: $143
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $160 |
| ABBVIE INC. | 2 | $136 |
| Novartis Pharmaceuticals Corporation | 3 | $85 |
| Lilly USA, LLC | 4 | $81 |
| Janssen Biotech, Inc. | 3 | $76 |
| Organon LLC | 2 | $15 |
Products named: SKYRIZI, TALTZ, TREMFYA, COSENTYX, ILUMYA, Rhapsido, Winlevi, VTAMA.
Industry payments across AR — which companies pay providers there.
